YCS23· AIGleam
Automating Data Entry for Clinical Trials
ActiveChecked 20h ago
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
NovelcareW23Empowering every doctor and every patient to participate in researchShared: healthcareActive
DelineateW25Agents for Accelerated Clinical Trial DesignShared: biotechActive
Baseline AIS24AI document creation and data management for clinical trialsShared: biotechInactive
ScoopF25Automating regulatory submissions for life sciencesShared: biotechActive
OsseusS26The frontier data platform for aligned health and biological AIShared: biotech, healthcareActive
Adjacent
Overlapping tags, a different niche.
MiracleW23Accelerate clinical trials with real-time, actionable insightsShared: biotech, healthcareActive
Data Driven BioscienceS18Cancer Diagnosis 10X faster, 10X cheaperShared: biotech, healthcareActive
NumenS23Engineering a future without cancer deaths.Shared: biotech, healthcareActive
Synthio LabsX25Agentic AI platform for Pharma GTM teamsShared: biotech, healthcareActive
FrekilX25RWE Generation in minutesShared: biotech, healthcareActive
Also from S23 in AI
Batchmates in Summer 2023.
Maven BioS23Live intelligence for biopharma teams.Active
Cair HealthS23AI Agents for Healthcare RCMActive
- ContourS23AI voice agents for healthcare operational callsActive
Empirical HealthS23Don't die of heart disease. Empirical is the first AI-native heart…Active
Healthtech 1S23Navigating patients to the right place, first time.Active
- Kips HealthS23The only patient engagement software that pays you.Inactive
About Gleam
Gleam automates data entry for clinical research sites.
San Francisco, CA, USA
Gleam: questions
Which YC batch was Gleam in?
Gleam was in Y Combinator's Summer 2023 batch (S23).
Is Gleam still active?
Y Combinator lists Gleam as active.
Where is Gleam based?
Gleam lists San Francisco, CA, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.